Clinical Study

Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study

Figure 1

Course of treatment: imiquimod and SAK (patients #1, #4, and #7). (a) Baseline; (b) week 2; (c) follow-up 4 weeks after end of treatment.
135916.fig.001a
(a)
135916.fig.001b
(b)
135916.fig.001c
(c)